A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions ; volume:20 ; number:1 ; day:18 ; month:2 ; year:2020 ; pages:1-9 ; date:12.2020
BMC cardiovascular disorders ; 20, Heft 1 (18.2.2020), 1-9, 12.2020
- Urheber
-
Kook, Hyungdon
Joo, Hyung Joon
Park, Jae Hyoung
Hong, Soon Jun
Yu, Cheol Woong
Lim, Do-Sun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12872-020-01381-9
- URN
-
urn:nbn:de:101:1-2020052801123207146065
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kook, Hyungdon
- Joo, Hyung Joon
- Park, Jae Hyoung
- Hong, Soon Jun
- Yu, Cheol Woong
- Lim, Do-Sun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs
Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis
Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis
Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion
In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario
Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches
Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions
Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients
Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis
Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions
Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease
5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs